Natco Pharma

{
  "main_header": {
    "sid": 156274,
    "name": "Natco Pharma",
    "stock_name": "Natco Pharma",
    "full_name": "Natco Pharma Ltd.",
    "name_url": "stocks-analysis/natco-pharma",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "853.70",
    "chg": 29.8,
    "chgp": "3.62%",
    "dir": 1,
    "prev_price": "823.90",
    "mcapval": "15,264.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524816,
    "symbol": "NATCOPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE987B01026",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "6.18 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/natco-pharma-156274-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Natco Pharma Ltd. Opens with Strong Gap Up, Reflecting Positive Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-opens-with-strong-gap-up-reflecting-positive-market-sentiment-3817730",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NatcoPharmaLtd_gapup_3817730.png",
        "date": "2026-02-03 09:43:37",
        "description": "Natco Pharma Ltd. commenced trading on 3 Feb 2026 with a notable gap up, opening 6.87% higher than its previous close, reflecting a robust start and positive market sentiment within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Natco Pharma Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3815221",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NatcoPharmaLtd_technicaldot_3815221.png",
        "date": "2026-02-02 08:00:24",
        "description": "Natco Pharma Ltd. has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend as of early February 2026. This change is underscored by a complex interplay of technical indicators, including bearish MACD and Bollinger Bands on weekly and monthly charts, alongside a mildly bullish daily moving average and a mixed RSI profile. Investors should carefully analyse these signals amid the company’s recent price performance and sector dynamics."
      },
      {
        "title": "Natco Pharma Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3813480",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NatcoPharmaLtd_technicaldot_3813480.png",
        "date": "2026-02-01 08:00:19",
        "description": "Natco Pharma Ltd. has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance, despite a complex mix of indicator signals. The stock’s recent price action, combined with evolving technical parameters, suggests cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Natco Pharma Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3808594",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NatcoPharmaLtd_technicaldot_3808594.png",
        "date": "2026-01-29 08:00:13",
        "description": "Natco Pharma Ltd. has experienced a notable shift in its technical momentum, transitioning from a mildly bullish trend to a sideways pattern as of late January 2026. Despite a modest day gain of 0.78% to close at ₹820.00, the stock’s technical indicators present a complex picture, with bearish signals dominating weekly and monthly MACD and Bollinger Bands, while some oscillators and moving averages suggest pockets of bullishness. This nuanced technical landscape warrants a detailed analysis for investors seeking clarity on the stock’s near-term trajectory within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Natco Pharma Ltd. is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/natco-pharma-ltd-is-rated-hold-3802980",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NatcoPharmaLtd_mojoScore_3802980.png",
        "date": "2026-01-24 10:10:27",
        "description": "Natco Pharma Ltd. is currently rated 'Hold' by MarketsMOJO, a rating that was last updated on 12 January 2026. While this rating change took place earlier this month, the analysis and financial metrics discussed here reflect the company’s position as of 24 January 2026, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and technical outlook."
      },
      {
        "title": "Why is Natco Pharma Ltd. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-natco-pharma-ltd-fallingrising-3797261",
        "imagepath": "",
        "date": "2026-01-21 01:06:00",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Performance</strong></p>\n<p>Natco Pharma’s share price closed at ₹824.05, down by ₹21.15 or 2.5% on 20 January. This decline continues a three-day losing streak, during which the stock has fallen by 7.61%. The intraday low of ₹818.45 marked a 3.16% drop, with heavier trading volumes concentrated near this lower price point, signalling selling pressure. The stock’s performance has consistently lagged behind its sector and benchmark indices, underperforming the Pharmaceuticals &amp; Drugs sector by 0.37% on the day and the Sensex by a wider margin over recent periods.</p>\n<p>Over the past week, Natco Pharma’s shares have declined by 5.22%, significantly underperforming the Sensex’s 1.73% fall. The one-month and year-to-date returns also paint a bleak picture, w..."
      },
      {
        "title": "Natco Pharma Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3789160",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NatcoPharmaLtd_technicaldot_3789160.png",
        "date": "2026-01-12 08:00:15",
        "description": "Natco Pharma Ltd. has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from a strongly bullish stance to a more tempered mildly bullish outlook. Despite a recent downgrade in daily price performance, the stock’s technical parameters reveal a complex interplay of bullish and bearish signals across weekly and monthly timeframes, prompting a reassessment of its near-term trajectory within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Natco Pharma Ltd. is Rated Buy by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/natco-pharma-ltd-is-rated-buy-by-marketsmojo-3786719",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NatcoPharmaLtd_mojoScore_3786719.png",
        "date": "2026-01-09 10:10:44",
        "description": "Natco Pharma Ltd. is rated Buy by MarketsMOJO, with this rating last updated on 07 January 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 09 January 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and technical outlook."
      },
      {
        "title": "Natco Pharma Ltd. Forms Golden Cross, Signalling Potential Bullish Breakout",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-forms-golden-cross-signalling-potential-bullish-breakout-3783581",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NatcoPharmaLtd_goldencross_3783581.png",
        "date": "2026-01-06 18:00:26",
        "description": "Natco Pharma Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has recently formed a Golden Cross, a significant technical indicator where the 50-day moving average (DMA) has crossed above the 200-DMA. This development suggests a potential bullish breakout and a shift in long-term momentum, offering investors a fresh perspective on the stock’s future trajectory."
      }
    ],
    "total": 5594,
    "sid": "156274",
    "stock_news_url": "https://www.marketsmojo.com/news/natco-pharma-156274"
  },
  "announcements": [
    {
      "details": "Natco Pharma Limited has informed the Exchange regarding Investor Presentation Q2 FY 2019-2020",
      "source": "NSE",
      "caption": "Natco Pharma Limited - Investor Presentation",
      "datetime": "18-Nov-2019"
    },
    {
      "details": "Natco Pharma Limited has informed the Exchange regarding a press release dated November 14, 2019, titled \"Commercial Manufacturing Operations begin in NATCO s Visakhapatnam Formulation Facility \".",
      "source": "NSE",
      "caption": "Natco Pharma Limited - Press Release",
      "datetime": "15-Nov-2019"
    },
    {
      "details": "Natco Pharma Limited has informed the Exchange regarding a press release dated November 12, 2019, titled \"NATCO records INR 518.9 Crore consolidated revenue and INR 117.7 Crore of profit, after tax, for the Second Quarter, FY2019-20\".",
      "source": "NSE",
      "caption": "Natco Pharma Limited - Press Release",
      "datetime": "13-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "12 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Natco Pharma Ltd. has declared <strong>75%</strong> dividend, ex-date: 20 Nov 25",
          "dt": "2025-11-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Natco Pharma Ltd. has announced <strong>2:10</strong> stock split, ex-date: 26 Nov 15",
          "dt": "2015-11-26",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Natco Pharma Ltd. Opens with Strong Gap Up, Reflecting Positive Market Sentiment

2026-02-03 09:43:37

Natco Pharma Ltd. commenced trading on 3 Feb 2026 with a notable gap up, opening 6.87% higher than its previous close, reflecting a robust start and positive market sentiment within the Pharmaceuticals & Biotechnology sector.

Read full news article

Natco Pharma Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

2026-02-02 08:00:24

Natco Pharma Ltd. has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend as of early February 2026. This change is underscored by a complex interplay of technical indicators, including bearish MACD and Bollinger Bands on weekly and monthly charts, alongside a mildly bullish daily moving average and a mixed RSI profile. Investors should carefully analyse these signals amid the company’s recent price performance and sector dynamics.

Read full news article

Natco Pharma Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

2026-02-01 08:00:19

Natco Pharma Ltd. has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance, despite a complex mix of indicator signals. The stock’s recent price action, combined with evolving technical parameters, suggests cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Natco Pharma Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

2026-01-29 08:00:13

Natco Pharma Ltd. has experienced a notable shift in its technical momentum, transitioning from a mildly bullish trend to a sideways pattern as of late January 2026. Despite a modest day gain of 0.78% to close at ₹820.00, the stock’s technical indicators present a complex picture, with bearish signals dominating weekly and monthly MACD and Bollinger Bands, while some oscillators and moving averages suggest pockets of bullishness. This nuanced technical landscape warrants a detailed analysis for investors seeking clarity on the stock’s near-term trajectory within the Pharmaceuticals & Biotechnology sector.

Read full news article

Natco Pharma Ltd. is Rated Hold

2026-01-24 10:10:27

Natco Pharma Ltd. is currently rated 'Hold' by MarketsMOJO, a rating that was last updated on 12 January 2026. While this rating change took place earlier this month, the analysis and financial metrics discussed here reflect the company’s position as of 24 January 2026, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Read full news article

Why is Natco Pharma Ltd. falling/rising?

2026-01-21 01:06:00

Recent Price Movement and Market Performance

Natco Pharma’s share price closed at ₹824.05, down by ₹21.15 or 2.5% on 20 January. This decline continues a three-day losing streak, during which the stock has fallen by 7.61%. The intraday low of ₹818.45 marked a 3.16% drop, with heavier trading volumes concentrated near this lower price point, signalling selling pressure. The stock’s performance has consistently lagged behind its sector and benchmark indices, underperforming the Pharmaceuticals & Drugs sector by 0.37% on the day and the Sensex by a wider margin over recent periods.

Over the past week, Natco Pharma’s shares have declined by 5.22%, significantly underperforming the Sensex’s 1.73% fall. The one-month and year-to-date returns also paint a bleak picture, w...

Read full news article

Natco Pharma Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

2026-01-12 08:00:15

Natco Pharma Ltd. has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from a strongly bullish stance to a more tempered mildly bullish outlook. Despite a recent downgrade in daily price performance, the stock’s technical parameters reveal a complex interplay of bullish and bearish signals across weekly and monthly timeframes, prompting a reassessment of its near-term trajectory within the Pharmaceuticals & Biotechnology sector.

Read full news article

Natco Pharma Ltd. is Rated Buy by MarketsMOJO

2026-01-09 10:10:44

Natco Pharma Ltd. is rated Buy by MarketsMOJO, with this rating last updated on 07 January 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 09 January 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and technical outlook.

Read full news article

Natco Pharma Ltd. Forms Golden Cross, Signalling Potential Bullish Breakout

2026-01-06 18:00:26

Natco Pharma Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has recently formed a Golden Cross, a significant technical indicator where the 50-day moving average (DMA) has crossed above the 200-DMA. This development suggests a potential bullish breakout and a shift in long-term momentum, offering investors a fresh perspective on the stock’s future trajectory.

Read full news article

View All News